UK markets closed

Prothena Corporation plc (PRTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.41-0.96 (-3.06%)
At close: 04:00PM EDT
30.01 -0.40 (-1.32%)
After hours: 05:14PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
142,811
200,577
853
814
955
Operating expenses
Research development
98,881
82,284
74,884
50,836
101,183
Selling general and administrative
48,948
46,318
38,703
35,736
42,482
Total operating expenses
147,829
128,602
113,587
86,572
143,665
Operating income or loss
-5,018
71,975
-112,734
-85,758
-142,710
Interest expense
0
-
-
0
3,697
Total other income/expenses net
-130
-96
-62
257
-16,097
Income before tax
-4,433
71,921
-111,427
-77,298
-156,115
Income tax expense
-2,967
4,946
-283
379
-470
Income from continuing operations
-1,466
66,975
-111,144
-77,677
-155,645
Net income
-1,466
66,975
-111,144
-77,677
-155,645
Net income available to common shareholders
-1,466
66,975
-111,144
-77,677
-155,645
Basic EPS
-
1.51
-2.78
-1.95
-3.93
Diluted EPS
-
1.38
-2.78
-1.95
-3.93
Basic average shares
-
44,228
39,915
39,882
39,559
Diluted average shares
-
48,464
39,915
39,882
39,559
EBITDA
-
78,778
-105,757
-70,478
-149,202